Clinical trial
A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children
NCT00144430 is registered in ClinicalTrials.gov with Ann & Robert H Lurie Children's Hospital of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- August 31, 2008
- Enrollment
- 60 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.